Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

Giulia Morsica(Vita-Salute San Raffaele University), Antonella d’Arminio Monforte(University of Milan), Paola Cicconi(University of Oxford), Sabrina Bagaglio(Vita-Salute San Raffaele University), Maria Rosaria Capobianchi, Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Cristina Moioli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Pietro Caramello(Ospedale Amedeo di Savoia), Anna Orani(Alessandro Manzoni Hospital), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Giampietro Pellizzer, Giuliano Rizzardini
JAIDS Journal of Acquired Immune Deficiency Syndromes
July 20, 2009
10.1097/qai.0b013e3181add592
Cited by 19

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930